Safety Study of Erythropoietin (EPO) in Parkinson's Disease
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether recombinant human Erythropoietin (EPOrh) is
safe in the treatment of patients with Parkinson's Disease.
Phase:
Phase 1
Details
Lead Sponsor:
International Center for Neurological Restoration, Cuba